Live Breaking News & Updates on Division of medical oncology

Stay informed with the latest breaking news from Division of medical oncology on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Division of medical oncology and stay connected to the pulse of your community

Dr Goetz on the Early Pharmacokinetic Data With Neoadjuvant (Z)-endoxifen in ER+/HER2– Breast Cancer

Dr Goetz on the Early Pharmacokinetic Data With Neoadjuvant (Z)-endoxifen in ER+/HER2– Breast Cancer
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Matthewp-goetz , Division-of-medical-oncology , Department-of-oncology , Medical-oncology , Mayo-clinic ,

Two-Drug Combo Shows Promise as Treatment for Aggressive Form of Breast Cancer

University of Colorado cancer researchers explore ways to overcome resistance to a standard treatment for triple-negative breast cancer.

United-states , Colorado , American , Stephen-smoots , Todd-pitts , Cu-department-of-medicine , University-of-colorado-cancer-center , University-of-colorado-boulder , Cu-cancer-center-cell-technologies-shared-resource , American-cancer-society , Division-of-medical-oncology , Breast-cancer-research

Dr Merchán on the Role of Immunotherapy and TKI Combinations in RCC

Jaime R. Merchán, MD, discusses the current roles for immunotherapy and TKIs in patients with renal cell carcinoma.

Miami , Florida , United-states , Jaimer-merch , Department-of-medicine , Clinical-trials-program , Clinical-oncology-research-program , Sylvester-comprehensive-cancer-center , University-of-miami-miller-school-medicine , Division-of-medical-oncology , Trials-program

Handling Parenting Pressures

Recent report details the issues early-career oncologists experience regarding parental leave.

Sindhuj-malapati , Little-rock , Accreditation-council-for-graduate-medical-education , University-of-arkansas , Division-of-medical-oncology , Department-of-internal-medicine , Us-department-of-agriculture , Medical-oncology , Internal-medicine , Medical-sciences , Accreditation-council , Graduate-medical-education

Clinical trial results for new drug vs biliary tract cancer promising

Liver cancer is the four most common type of cancer in the Philippines after breast, lung and colon cancer and the second most common cause of death. The Philippines logged a total of 10,594 news cases and 9,953 deaths in 2020. The most common cause of liver cancer in the…

Philippine , Benguet , Philippines , Seoul , Soult-ukpyolsi , South-korea , Filipino , Eugenio-regala , Herdee-luna , Lotis-ramin , Astrazeneca , Division-of-medical-oncology

Dr Merchan on Key Data Supporting Pembrolizumab-Based Regimens in Advanced RCC

Jaime R. Merchán, MD, discusses the role of pembrolizumab plus axitinib or lenvatinib in previously untreated advanced renal cell carcinoma.

Jaimer-merch , Division-of-medical-oncology , Department-of-medicine , Clinical-trials-program , University-of-miami-health-system , Sylvester-comprehensive-cancer-center , Clinical-oncology-research-program , Medical-oncology , Trials-program , Miami-health-system , Cancers-symposium

KUCC Delivers Cutting-Edge Care for Urban and Rural Populations

Coverage from the Institute for Value-Based Medicine event with the University of Kansas Cancer Center in Kansas City, Kansas.

Kansas , United-states , University-of-kansas , Canada , Belgium , Australia , Kansas-city , University-of-kansas-medical-center , American , Joaquina-baranda , Roy-jensen , Mazinf-al-kasspooles

Dr Olazagasti on a Case-Based Discussion of ALK-Mutated NSCLC Treatment

Coral Olazagasti, MD, discusses her participation in a case-based discussion at the 21st Annual Winter Lung Cancer Conference®.

Miami , Florida , United-states , Division-of-medical-oncology , University-of-miami-miller-school-medicine , Department-of-medicine , Cancer-center , Coral-olazagasti , Clinical-medical-oncology , Medical-oncology , Miami-miller-school

Phase 2 Study of Denifanstat Looks to Add First-in-Class Agent to HER2+Breast Cancer Treatment Armamentarium

Phase 2 trial investigators hope denifanstat can be a key component in restoring sensitivity to HER2- positive metastatic breast cancer treatments.

Minnesota , United-states , Mayo-clinic-in-rochester , Karthikv-giridhar , Division-of-medical-oncology , Department-of-oncology , Breast-tumor-group , Medical-oncology , Mayo-clinic , Phase-efficacy-seen , Advanced-solid-tumors

Grivas Expands on Key Data From the 2023 ESMO Congress in Urothelial Cancer

Petros Grivas, MD, PhD, spotlights key advancements and research in urothelial cancer reported at the 2023 ESMO Congress, detailing findings from the phase 3 CheckMate 901, EV-302/KEYNOTE-A39, and THOR trials.

Petros-grivas , University-of-washington-school-medicine , Genitourinary-cancers-program , Clinical-research-division-at-fred-hutch , Division-of-medical-oncology , Science-summit , Medical-oncology , Washington-school , Clinical-research-division , Fred-hutch , Fred-hutch-cancer-center , Urothelial-cancer